ES488717A0 - Procedimiento para la obtencion de derivados de pirazol - Google Patents

Procedimiento para la obtencion de derivados de pirazol

Info

Publication number
ES488717A0
ES488717A0 ES488717A ES488717A ES488717A0 ES 488717 A0 ES488717 A0 ES 488717A0 ES 488717 A ES488717 A ES 488717A ES 488717 A ES488717 A ES 488717A ES 488717 A0 ES488717 A0 ES 488717A0
Authority
ES
Spain
Prior art keywords
procedure
obtaining
pirazol derivatives
pirazol
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES488717A
Other languages
English (en)
Other versions
ES8102120A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of ES488717A0 publication Critical patent/ES488717A0/es
Publication of ES8102120A1 publication Critical patent/ES8102120A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES488717A 1979-02-19 1980-02-18 Procedimiento para la obtencion de derivados de pirazol Expired ES8102120A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792906252 DE2906252A1 (de) 1979-02-19 1979-02-19 Pyrazolderivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES488717A0 true ES488717A0 (es) 1980-12-16
ES8102120A1 ES8102120A1 (es) 1980-12-16

Family

ID=6063264

Family Applications (1)

Application Number Title Priority Date Filing Date
ES488717A Expired ES8102120A1 (es) 1979-02-19 1980-02-18 Procedimiento para la obtencion de derivados de pirazol

Country Status (8)

Country Link
US (1) US4258047A (es)
EP (1) EP0014847A1 (es)
JP (1) JPS55120583A (es)
AU (1) AU5556280A (es)
DE (1) DE2906252A1 (es)
ES (1) ES8102120A1 (es)
IL (1) IL59410A0 (es)
ZA (1) ZA80922B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826868A (en) * 1986-05-29 1989-05-02 Ortho Pharmaceutical Corporation 1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use
AU611437B2 (en) * 1987-05-29 1991-06-13 Ortho Pharmaceutical Corporation Pharmacologically active 2- and 3-substituted (1',5'-diaryl-3-pyrazolyl)-n-hydroxypropanamides and method for synthesizing the same
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
GB9714303D0 (en) * 1997-07-07 1997-09-10 Pharmacia & Upjohn Spa 5-(3-phenyl-3-oxo-propyl)-1H-tetrazole derivatives
DE10149370A1 (de) * 2001-10-06 2003-04-10 Merck Patent Gmbh Pyrazolderivate
AU2003275637A1 (en) * 2002-10-24 2004-05-13 Wakamoto Pharmaceutical Co., Ltd. Pyrazole-4-alkanoate derivatives inhibiting cyclooxygenase and 5-lipoxygenase
DE10315569A1 (de) 2003-04-05 2004-10-14 Merck Patent Gmbh Substituierte Pyrazolverbindungen
DE10315573A1 (de) 2003-04-05 2004-10-14 Merck Patent Gmbh Substituierte Pyrazole
DE10315572A1 (de) * 2003-04-05 2004-10-14 Merck Patent Gmbh Substituierte Pyrazole
DE10315571A1 (de) 2003-04-05 2004-10-14 Merck Patent Gmbh Pyrazolverbindungen
JP5269795B2 (ja) * 2006-09-29 2013-08-21 グリーン・クロス・コーポレイション カンナビノイドｃｂ１受容体アンタゴニストとしてのヘテロアリール−ピラゾール誘導体
WO2009078498A1 (en) * 2007-12-17 2009-06-25 Green Cross Corporation Biarylpyrazole 4-carboxamides as cannabinoid cb1 receptor ligands

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE663344A (es) * 1964-05-04
DE1595920B2 (de) * 1964-11-04 1978-08-10 Merck Patent Gmbh, 6100 Darmstadt 4-(co-Piperazinoalkyl)-pyrazole, ihre Salze und Verfahren zu ihrer Herstellung
CH535777A (de) * 1967-03-01 1973-04-15 Ciba Geigy Ag Verfahren zur Herstellung neuer azacycloaliphatischer Verbindungen
BE755924A (fr) * 1969-09-12 1971-02-15 Byk Gulden Lomberg Chem Fab Derives d'acide pyrazole-4-acetique, leur procede de preparation et medicaments en contenant
DE2526469A1 (de) * 1975-06-13 1976-12-30 Bayer Ag 1-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
ZA80922B (en) 1981-02-25
JPS55120583A (en) 1980-09-17
ES8102120A1 (es) 1980-12-16
AU5556280A (en) 1980-08-28
EP0014847A1 (de) 1980-09-03
IL59410A0 (en) 1980-05-30
US4258047A (en) 1981-03-24
DE2906252A1 (de) 1980-08-28

Similar Documents

Publication Publication Date Title
ES493633A0 (es) Procedimiento para la obtencion de muramilpeptidos
ES497884A0 (es) Procedimiento para preparar derivados de 2-amino-4-hidroxi- quinazolina
ES495214A0 (es) Procedimiento para la obtencion de nuevos derivados defor- miltilosinos
ES496848A0 (es) Procedimiento para la obtencion de azoliloxi-carboxil-n- oxiamidas
ES489934A0 (es) Procedimiento para la preparacion de derivados de pipreridi-na
MX5880E (es) Procedimiento para preparar derivados de bencilimidazol
ES492891A0 (es) Procedimiento para la preparacion de derivados triyodados deacido 5-amino- isoftalico
ES488635A0 (es) Procedimiento para preparar derivados de pirimidina
ES493770A0 (es) Procedimiento para la obtencion de poliarilensulfuros
ES494119A0 (es) Procedimiento para preparar derivados de 3-aminoproxiarilo
ES493330A0 (es) Procedimiento para la obtencion de nikkomicinas de efecto pesticida
ES493771A0 (es) Procedimiento para la obtencion de poliarilensulfuros
MX6806E (es) Procedimiento para producir derivados de carboestirilo
ES488772A0 (es) Procedimiento para preparar derivados de pirimidona
AR226694A1 (es) Procedimiento para obtener nuevos derivados de antraciclina
ES504256A0 (es) Procedimiento para la obtencion de derivados de triazolil- propenol
AR227525A1 (es) Procedimiento para obtener derivados de acidos ciclohexancarboxilicos
ES488717A0 (es) Procedimiento para la obtencion de derivados de pirazol
ES490988A0 (es) Procedimiento para la obtencion de butirolactona
ES490475A0 (es) Procedimiento para la obtencion de metilolaminotriazinas eteradas
MX6971E (es) Procedimiento para preparar derivados de tetrahidroquinolina
ES490797A0 (es) Procedimiento para la obtencion de derivados de benzotiazol
ES488810A0 (es) Procedimiento para la obtencion de diazatriciclos
ES492394A0 (es) Procedimiento para preparar derivados de pirimidina
ES493068A0 (es) Procedimiento para la obtencion de derivados del amino-tia- diazolilo